Efficacy and factors associated with reactivation following intravitreal ranibizumab or conbercept for retinopathy of prematurity.

Lucentis (ranibizumab) - Roche, Novartis

Lumitin (conbercept) - Chengdu Kanghong Pharma

http://www.ncbi.nlm.nih.gov/pubmed/41797776

Ge Mu; Huanhuan Zhao; Jiafen Liu; Jianxun Wang; Jiao Zheng; Jing Li; Qiuhui Liu; Suzhen Xie; Xuelin Huang

Mar 9, 2026